Disclosures for "Phase 1, Open-label, Fixed-sequence, Bidirectional, Pharmacokinetic (PK) Drug-drug Interaction (DDI) Study Between Cannabidiol (CBD) and Cenobamate (CNB) in Healthy Adult Participants"